TOP2A and prostate cancer: Accumulating researches have shown that TOP2A is overexpressed in many types of tumors, such as pancreatic cancer, breast cancer, prostate cancer, colon cancer, gastroesophageal and esophageal cancer, hepatoblastoma and malignant peripheral nerve sheath tumor 9-12.